Atlas Trials

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Clinical trial NCT06219902 · COMPLETED

Trial details

NCT number
NCT06219902
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Start date
2024-01-08
Primary completion
2024-04-15
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.